FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

American Health Packaging Zolpidem Tartrate Tablets 5 mg Recall

Zolpidem Tartrate Tablets 5 mg, 10 tablets per blister, 10 blisters per carton, 100 car…

American Health Packaging · Columbus, OH

Risk level
Class II
Reported by FDA
Aug 14, 2013
Recall ID
D-856-2013
Check your lot numberHow we source this data

Summary

American Health Packaging recalled Zolpidem Tartrate Tablets 5 mg starting May 21, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-856-2013 on Aug 14, 2013. Reason: Unit Dose Mispackaging: This recall event is due to a random undetected packaging issue which could increase the potential for a small number of individual unit dose blisters to be packed with more than one tablet. Status: Terminated.

Why it was recalled

Unit Dose Mispackaging: This recall event is due to a random undetected packaging issue which could increase the potential for a small number of individual unit dose blisters to be packed with more than one tablet.

Product description

Zolpidem Tartrate Tablets 5 mg, 10 tablets per blister, 10 blisters per carton, 100 cartons per box, Rx Only, Manufactured for Wockhardt USA LLC., Parsippany, NJ 07054 by Wockhardt Limited, Mumbai, India, NDC 68084-225-01

Lot numbers, UPCs & expiration codes

Lot #: 114215, Exp 7/13; 114216, Exp 7/13; 114217, Exp 7/13; 120087, Exp 9/13; 120295, Exp 9/13; 121573, Exp 6/14; 123572, Exp 9/14; 123983, Exp 9/14; 130071, Exp 2/15

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-856-2013
Classification
Class II
Status
Terminated
Recall initiated
May 21, 2013
FDA report date
Aug 14, 2013
Quantity
48.230 carton units
Recall type
Voluntary: Firm initiated
Recalling firm
American Health Packaging

Original FDA data

Every field from FDA enforcement report D-856-2013, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
65495
Address
2550 John Glenn Ave
Address (line 2)
Suite A
Code information
Lot #: 114215, Exp 7/13; 114216, Exp 7/13; 114217, Exp 7/13; 120087, Exp 9/13; 120295, Exp 9/13; 121573, Exp 6/14; 123572, Exp 9/14; 123983, Exp 9/14; 130071, Exp 2/15
Postal code
43217-1188
Report date
Aug 14, 2013
Product type
Drugs
Recall number
D-856-2013
Classification
Class II
Recalling firm
American Health Packaging
Product quantity
48.230 carton units
Termination date
Dec 24, 2013
Reason for recall
Unit Dose Mispackaging: This recall event is due to a random undetected packaging issue which could increase the potential for a small number of individual unit dose blisters to be packed with more than one tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zolpidem Tartrate Tablets 5 mg, 10 tablets per blister, 10 blisters per carton, 100 cartons per box, Rx Only, Manufactured for Wockhardt USA LLC., Parsippany, NJ 07054 by Wockhardt Limited, Mumbai, India, NDC 68084-225-01
Distribution pattern
Nationwide.
Recall initiation date
May 21, 2013
Initial firm notification
Letter
Center classification date
Aug 8, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-856-2013, published Aug 14, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls